BTW, the insider, Dr. Srini Akkaraju, M.D., Ph.D., who acquired almost 1M shares over a week ago, is actually the primary founder of Samsara BioCapital, an Biotech investment firm just filed with SEC in March/2017 with an initial $300M capital. Detailed info can be found via this link
https://www.sec.gov/Archives/edgar/data/1699737/000169973717000003/xslFormDX01/primary_doc.xml
Prior to the crash BioCapital/Dr. Srini Akkaraju had already invested $14M in Versartis (purchased almost 1.5M shares at $12.25). With the doctor's medical background, I think the investor should have a very good knowledge about Somavaratan and decided to put that large amount of money in Versartis. And with the recent purchases, there is a high chance that BioCapital will acquire VSAR.
Also some other Samsara initial investments:
https://www.businesswire.com/news/home/20170421005129/en/Syros-Announces-35-Million-Private-Placement
GLTA
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM